James Jones
Pulmonary Disease · Charlotte, NCNPI 1740200047
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 112 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AstraZeneca at 25.3% of the total. Reporting peaked in 2019 at $1,255 and has fallen 88.3% since, to $148 in 2022.
Across 112 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$514
- GSK$343
- Mylan Specialty L.p.$246
- Boehringer Ingelheim$230
- Sanofi$131
- Circassia Inc.$108
- plus $458 from 15 others
What the payments were for
- Food & beverage$2,030100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 24 | $514 |
| GSK | 21 | $343 |
| Mylan Specialty L.p. | 16 | $246 |
| Boehringer Ingelheim | 14 | $230 |
| Sanofi | 6 | $131 |
| Circassia Inc. | 8 | $108 |
| Viiv Healthcare Company | 1 | $86 |
| Grifols USA, LLC | 4 | $71 |
| Insmed, Inc. | 2 | $55 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $37 |
| Genentech USA, Inc. | 2 | $33 |
| Johnson & Johnson | 2 | $30 |
| Amgen(2 entities) | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Merck | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| AbbVie | 1 | $14 |
| Boston Scientific | 1 | $14 |
| Advanced Respiratory, Inc | 1 | $14 |
| Optinose US, Inc. | 1 | $13 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$122
How this compares
$2,030 in reported general payments places this provider in the 55th percentile of 393 pulmonary disease providers in North Carolina.
Other pulmonary disease in Charlotte
- Jaspal SinghCharlotte$191K
- Selwyn SpangenthalCharlotte$70K
- Muhammad RashadCharlotte$14K
- Michael PritchettPinehurst$1.3M
- Michael WertGreensboro$412K
- Eugene BleeckerWinston Salem$357K
- Bradley IcardPinehurst$299K
- James DonohueChapel Hill$271K
- Eric MeltzerDurham$262K
- Daniel BreaultWilmington$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.